British Society of Gastroenterology guidelines on the investigation of suspected liver disease in adults

Chronic liver disease is increasingly prevalent yet often undiagnosed. The British Society of Gastroenterology (BSG) published guidance on the investigation of abnormal liver blood tests in 2000, and this was comprehensively updated in 2018. Since then, significant developments including the adoption of new nomenclature for steatotic liver disease (SLD), advances in non-invasive fibrosis assessment and expanding strategies for early detection in primary care have necessitated further revision. This update was commissioned by the BSG Clinical Services Committee. The guideline scope was defined a priori and focused on the investigation of adults with suspected liver disease. A multidisciplinary guideline development group generated key clinical questions and conducted a systematic literature review. Recommendations were formulated using Appraisal of Guidelines for Research and Evaluation II (AGREE II) and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) methodology. Major updates include integration of the revised SLD terminology, updated pathways for fibrosis risk stratification, and recommendations on targeted case finding in groups at highest risk, including people with type 2 diabetes mellitus and those with harmful alcohol consumption. Clear, evidence-based recommendations are presented for the investigation of abnormal liver blood tests, evaluation of imaging findings suggestive of liver disease, case finding among people with recognised risk factors, use of non-invasive fibrosis assessment tools and indications for referral to secondary care. The guidelines aim to standardise diagnostic pathways, facilitate earlier detection of clinically significant liver disease, reduce unwarranted variation and support scalable models of care across primary and secondary healthcare settings.

Authors

Institutions

Publication Details

Journal
Gut
Published
2026-11-17
DOI
https://doi.org/10.1136/gutjnl-2026-339875
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

British Society of Gastroenterology guidelines on the investigation of suspected liver disease in adults

Tom Pembroke, John Francis Dillon, Edmund M. Godfrey, Helen Jarvis et al.
1 links
Gut
Liver Disease Diagnosis and Treatment
article

British Society of Gastroenterology guidelines on the investigation of suspected liver disease in adults

Tom Pembroke, John Francis Dillon, Edmund M. Godfrey, Helen Jarvis, Vanessa Hebditch, Latif Rahman, Girish L. Gupte, James M Franklin, Quentin Mark Anstee, Alastair J O'Brien, Ahmed Mohamed Elsharkawy, David Blane, Laura Kent, Jeremy Cobbold, Palak Jitendrakumar Trivedi, Ashwin Dhanda, Stuart McPherson, Jeremy Tomlinson, Hazel Borthwick, Wenhao Li, James A Richards, Nick R Murch, Peter Walsh, Neil McDougall, Teesha Joshy, Kim Yun, Erica Fairbairn
article en

Abstract

Chronic liver disease is increasingly prevalent yet often undiagnosed. The British Society of Gastroenterology (BSG) published guidance on the investigation of abnormal liver blood tests in 2000, and this was comprehensively updated in 2018. Since then, significant developments including the adoption of new nomenclature for steatotic liver disease (SLD), advances in non-invasive fibrosis assessment and expanding strategies for early detection in primary care have necessitated further revision. This update was commissioned by the BSG Clinical Services Committee. The guideline scope was defined a priori and focused on the investigation of adults with suspected liver disease. A multidisciplinary guideline development group generated key clinical questions and conducted a systematic literature review. Recommendations were formulated using Appraisal of Guidelines for Research and Evaluation II (AGREE II) and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) methodology. Major updates include integration of the revised SLD terminology, updated pathways for fibrosis risk stratification, and recommendations on targeted case finding in groups at highest risk, including people with type 2 diabetes mellitus and those with harmful alcohol consumption. Clear, evidence-based recommendations are presented for the investigation of abnormal liver blood tests, evaluation of imaging findings suggestive of liver disease, case finding among people with recognised risk factors, use of non-invasive fibrosis assessment tools and indications for referral to secondary care. The guidelines aim to standardise diagnostic pathways, facilitate earlier detection of clinically significant liver disease, reduce unwarranted variation and support scalable models of care across primary and secondary healthcare settings.

Gut
University Hospitals Birmingham NHS Foundation Trust (GB), Queen Mary University of London (GB), Royal Free London NHS Foundation Trust (GB), University of Dundee (GB), County Durham and Darlington NHS Foundation Trust (GB), Princess Alexandra Hospital NHS Trust (GB), University Hospital of Wales (GB), Newcastle upon Tyne Hospitals NHS Foundation Trust (GB), Great Western Hospital (GB), University Hospitals of Leicester NHS Trust (GB), University Hospital Southampton NHS Foundation Trust (GB), National Institute for Health and Care Research (GB), University of Oxford (GB), NIHR Oxford Musculoskeletal Biomedical Research Centre (GB), NIHR Birmingham Liver Biomedical Research Unit (GB), Oxford Centre for Diabetes, Endocrinology and Metabolism (GB), Royal Victoria Hospital (GB), NIHR Newcastle Biomedical Research Centre (GB), Great Western Hospitals NHS Foundation Trust (GB), Birmingham Women’s and Children’s NHS Foundation Trust (GB), Addenbrooke's Hospital (GB), Blizard Institute (GB), University College London (GB), University of Glasgow (GB), Cardiff University (GB), University of Birmingham (GB), Newcastle University (GB), University of Plymouth (GB), Bournemouth University (GB)
National Institute for Health and Care Research, University College London, University College London Hospitals NHS Foundation Trust
Good health and well-being
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon